These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6143287)

  • 61. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 62. A cellular mechanism of reward-related learning.
    Reynolds JN; Hyland BI; Wickens JR
    Nature; 2001 Sep; 413(6851):67-70. PubMed ID: 11544526
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prolactin induces grooming in the rat: possible involvement of nigrostriatal dopaminergic system.
    Drago F; Bohus B; Canonico PL; Scapagnini U
    Pharmacol Biochem Behav; 1981 Jul; 15(1):61-3. PubMed ID: 7291231
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
    Li SJ; Sivam SP; McGinty JF; Huang YS; Hong JS
    J Pharmacol Exp Ther; 1987 Nov; 243(2):792-8. PubMed ID: 2445959
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of cortical ablation on multiple unit activity in the striatum following dexamphetamine.
    Warenycia MW; McKenzie GM; Murphy M; Szerb JC
    Neuropharmacology; 1987 Aug; 26(8):1107-14. PubMed ID: 2889162
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 67. Dopamine's Effects on Corticostriatal Synapses during Reward-Based Behaviors.
    Bamford NS; Wightman RM; Sulzer D
    Neuron; 2018 Feb; 97(3):494-510. PubMed ID: 29420932
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
    Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
    Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
    [No Abstract]   [Full Text] [Related]  

  • 69. Single Synapse Indicators of Impaired Glutamate Clearance Derived from Fast iGlu
    Dvorzhak A; Helassa N; Török K; Schmitz D; Grantyn R
    J Neurosci; 2019 May; 39(20):3970-3982. PubMed ID: 30819797
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The modulation of dopamine receptors in rat striatum.
    Stefani A; Pisani A; Bernardi G; Bonci A; Mercuri NB; Stratta F; Calabresi P
    J Neural Transm Suppl; 1995; 45():61-6. PubMed ID: 8748610
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacological analysis of the functional ontogeny of the nigrostriatal dopaminergic neurons.
    Cheronis JC; Erinoff L; Heller A; Hoffmann PC
    Brain Res; 1979 Jun; 169(3):545-60. PubMed ID: 36209
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation.
    Korchounov A; Meyer MF; Krasnianski M
    J Neural Transm (Vienna); 2010 Dec; 117(12):1359-69. PubMed ID: 21076988
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway.
    Rice ME; Cragg SJ
    Brain Res Rev; 2008 Aug; 58(2):303-13. PubMed ID: 18433875
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mesocortical dopaminergic neurons. 2. Electrophysiological consequences of terminal autoreceptor activation.
    Gariano RF; Sawyer SF; Tepper JM; Young SJ; Groves PM
    Brain Res Bull; 1989 Mar; 22(3):517-23. PubMed ID: 2713724
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-glutamatergic effects of clozapine.
    Lidsky TI; Yablonsky-Alter E; Zuck L; Banerjee SP
    Neurosci Lett; 1993 Dec; 163(2):155-8. PubMed ID: 7906022
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Presynaptic long-term changes in excitability of the corticostriatal pathway.
    Garcia-Munoz M; Young SJ; Groves PM
    Neuroreport; 1992 Apr; 3(4):357-60. PubMed ID: 1325202
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist.
    Hanson G; Alphs L; Pradhan S; Lovenberg W
    Neuropharmacology; 1981 Jun; 20(6):541-8. PubMed ID: 6165922
    [No Abstract]   [Full Text] [Related]  

  • 78. Primate Nigrostriatal Dopamine System Regulates Saccadic Response Inhibition.
    Ogasawara T; Nejime M; Takada M; Matsumoto M
    Neuron; 2018 Dec; 100(6):1513-1526.e4. PubMed ID: 30415993
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Activation by stress of the habenulo-interpeduncular substance P neurons in the rat.
    Lisoprawski A; Blanc G; Glowinski J
    Neurosci Lett; 1981 Aug; 25(1):47-51. PubMed ID: 6168982
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?
    Lehmann J; Langer SZ
    Neuroscience; 1983 Dec; 10(4):1105-20. PubMed ID: 6320043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.